Long-Term Impact of First-Line Anti-Retroviral Therapy on HiV-1 Positive Patients: A Retrospective Study in Karnataka, India
The Open AIDS Journal · 07.02.2022 · 16 (1)
DOI: 10.2174/18746136-v16-e2112200 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open AIDS Journal, erschienen am 07.02.2022. Verfasst von Aishah Khan und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
In resource-limited settings like India, the treatment efficacy of ART is monitored through CD4 count and clinical indicators. The objective of this study is to assess outcomes and indicators of treatment failure in patients on long-term first-line ART.
Methods
We carried out a retrospective study using data from 851 patients collected from ART centers established in two tertiary care hospitals of Kasturba Medical College, Mangalore. All HIV-1 positive patients initiated on first-line therapy from 2001 to 2009 were monitored.
Results
Of the 851 patients, 62.6% were males, median age was 37 years and 90% were infected through heterosexual contact. About 21% of the total patients surveyed were reported to have died, 2.5% withdrew treatment, 2.5% were transferred out and 1.5% were lost to follow up. Moreover, 11.2% of the population were reported to have switched to second-line therapy due to poor adherence (p=0.0001). Of those evaluated for failure (n=95), 36.8% were due to both immunological and virological failure, and 34.7% were due to virological failure. Median CD4 count at initiation was 260 cells/mm 3 , while the median recent CD4 count was 555 cells/mm 3 . In our study, an association between adherence with outcome was found to be statistically significant.
Conclusion
To conclude, this study proves that better adherence led to a favorable long-term outcome.
Zitieren
APA
Khan, A., Achappa, B., Kulkarni, V., Holla, R., Dsouza, N. V., Unnikrishnan, B., Ramapuram, J. T., & Madi, D. (2022). Long-Term Impact of First-Line Anti-Retroviral Therapy on HiV-1 Positive Patients: A Retrospective Study in Karnataka, India. The Open AIDS Journal, 16(1). https://doi.org/10.2174/18746136-v16-e2112200
Vancouver
Khan A, Achappa B, Kulkarni V, Holla R, Dsouza NV, Unnikrishnan B, et al. Long-Term Impact of First-Line Anti-Retroviral Therapy on HiV-1 Positive Patients: A Retrospective Study in Karnataka, India. The Open AIDS Journal. 2022;16(1). doi:10.2174/18746136-v16-e2112200
BibTeX
@article{Khan2022,
author = {Khan, Aishah and Achappa, Basavaprabhu and Kulkarni, Vaman and Holla, Ramesh and Dsouza, Nikhil Victor and Unnikrishnan, Bhaskaran and Ramapuram, John T. and Madi, Deepak},
title = {Long-Term Impact of First-Line Anti-Retroviral Therapy on HiV-1 Positive Patients: A Retrospective Study in Karnataka, India},
journal = {The Open AIDS Journal},
year = {2022},
volume = {16},
number = {1},
doi = {10.2174/18746136-v16-e2112200}
}
EUVIMED